- Report
- March 2025
- 186 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 103 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- June 2024
- 377 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- March 2024
- 351 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- October 2024
- 194 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 191 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- January 2025
- 163 Pages
Global
From €2854EUR$2,990USD£2,391GBP
- Report
- October 2024
- 186 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- September 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- August 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- March 2025
- 181 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- March 2025
- 89 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- March 2025
- 244 Pages
Global
From €5201EUR$5,450USD£4,358GBP
- Report
- August 2024
- 294 Pages
Global
From €3985EUR$4,175USD£3,338GBP
- Report
- March 2025
- 179 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- March 2025
- 127 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- February 2025
- 185 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2024
- 264 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- July 2024
- 150 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- May 2024
- 160 Pages
Global
From €4723EUR$4,949USD£3,957GBP

The Antibody Production market is a segment of the biopharmaceutical industry that focuses on the production of antibodies for therapeutic and diagnostic purposes. Antibodies are proteins that are produced by the immune system to recognize and bind to specific antigens, such as bacteria and viruses. Antibody production involves the use of recombinant DNA technology to produce large quantities of antibodies for use in research, diagnostics, and therapeutics. The market is driven by the increasing demand for biopharmaceuticals, as well as the development of new technologies and techniques for producing antibodies.
The Antibody Production market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more